Osteoporosis - The need for a paradigm shift

Annals of the Academy of Medicine Singapore

Volumn 27, Issue 1, 1998, Pages 100-104

  Leong, K H ^a,b  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b GLENEAGLES HOSPITAL   (Singapore)

Author keywords

Bone densitometry; Diagnosis; Fracture; Treatment

Indexed keywords

ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; FLUORIDE SODIUM; HORMONE; VITAMIN D DERIVATIVE;

DIFFERENTIAL DIAGNOSIS; HIP FRACTURE; HORMONAL THERAPY; HUMAN; MORBIDITY; MORTALITY; OSTEOPOROSIS; REVIEW; SPINE FRACTURE; WRIST FRACTURE;

EID: 0031960515     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Cummings S R, Black D M, Rubin S M. Life-time risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women Arch Intern Med 1989;149:2445-8.
2. Cooper C, Campion G, Melton L J Hip fractures in the elderly, a world-wide projection Osteoporosis Int 1992; 2:285-9.
3. Lee S T. Osteoporosis and the incidence of hip fractures in Singapore. Proceedings of the Third Asian Symposium on Osteoporosis, 1992.
4. Lord S R, Sambrook P N, Gilbert C, Kelly P J, Nyugen T, Webster I W, et al. Postural stability, falls and fractures in the elderly, results from the Dubbo Osteoporosis Epidemiology Study. Med J Aust 1994; 160:684-91
5. National Osteoporosis Foundation Working Group on Vertebral Fractures, Report assessing vertebral fractures. J Bone Miner Res 1995; 10:518-23
6. Cummings S R, Nevitt M C, Browner W S, Stone K, Fox K M, Ensrud K E, et al. Risk factors for hip fractures in white women N Engl J Med 1995; 332:767-73.
7. Leong K H, Feng P H. Bone mineral density measurements using the Hologic QDR 2000 densitometer in 175 Singaporean women aged 21-80. Singapore Med J 1997;38:25-6
8. Leong K H. Ultrasound of the tibia - precision error, left versus right sides and correlation with bone density. Ann Acad Med Singapore 1997; 26:747-9.
9. Ho S C, Leung P C, Swaminathan R, Chan C, Chan S S, Fan Y K, et al Determinants of bone mass in Chinese women aged 21-40 years. II Pattern of dietary calcium and association with bone mineral density Osteoporosis Int 1994; 4 167-75
10. Leong K H. Inter-ethnic differences in vitamin D receptor genotypes Proceedings of 19th ILAR Congress of Rheumatology; 1997 June 19-11, Singapore Singapore: Communications Consultants, 1997.
11. Paganini-Hill A, Ross R K, Gerkins V R, Henderson B E, Arthur M, Mack T M, et al. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28-31.
12. Colditz G A, Hankinson S E, Hunter D J, Willett W C, Manson J E, Stampfer M J, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332:1589-93.
13. Delmas P D, Bjarnason N H, Mitlak B H, Ravoux A C, Shah A S, Huster W J. Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337:1641-7.
14. Jones G, Nguyen T, Sambrook P N, Kelly P J, Eisman J A. Progressive femoral neck bone loss in the elderly: longitudinal findings from the Dubbo Osteoporosis Epidemiology Study. BMJ 1994; 309:691-5.
15. Storm T, Thamsborg G, Steiniche T, Genant H K, Sorensen O H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322:1265-71.
16. Hams S T, Watts N B, Jackson R D. Four year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 1993; 95:557-67.
17. Liberman U A, Weles N B, Broll J,Minne H W, Quan H, Bell N H, et al. Effect of oral alendronate on bone mineral density and fracture incidence in postmenopausal osteoporosis. N Engl J Med 1995; 333:1437-43.
18. Black D M, Cummings S R, Karpf D B, Cauley J A, Thompson D E, Nevitt M C, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 384:1535-41.
19. Chapuy M C, Arlot M E, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327:1637-42.
20. Lips P, Graafmans W C, Ooms M E, Bezemer P D, Bouter L M. Vitamin D supplementation and fracture incidnce in elderly persons. Ann Intern Med 1996; 124 400-6.
21. Tilyard M W, Spears G F S, Thomson J, Dovey S Treatment of postmenopausal osteoporosis with calcitriol or calcium N Engl J Med 1992; 326:357-62.
22. Sambrook P N, Birmingham J, Kelly P J, Kempler S, Pocock N A, Eisman J A Prevention of corticosteroid osteoporosis; a comparison of calcium, calcitriol and calcitonin N Engl J Med 1993; 328:1747-52.
23. Overgaard K, Hansen M, Jensen S B, Christiansen C Effect of salcatonin given intranasally on bone mass and fractures rates in established osteoporosis: a dose response study. BMJ 1992; 305:556-61.
24. Riggs B L, O'Fallon W M, Lane A, Hodgson S F, Wahner H W, Muhs J, et al. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observation and additional analyses J Bone Miner Res 1994; 9:265-76.